Vanda Pharmaceuticals (VNDA) Stock Chart & Stock Price History → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free VNDA Stock Alerts $5.11 +0.10 (+2.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Vanda Pharmaceuticals Stock Price Performance5 Day Performance+2.61%1 Month Performance+9.19%3 Month Performance+10.85%6 Month Performance+31.03%Year-To-Date Performance+21.09%1 Year Performance-15.68% Receive VNDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here VNDA Stock Chart for Sunday, June, 2, 2024 VNDA Chart by TradingView Vanda Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$5.01$5.11+2.00%$5.19$5.05763,425 shs$297.40 million05/30/2024$4.92$5.01+1.83%$5.04$4.88441,499 shs$291.58 million05/29/2024$4.98$4.92-1.20%$5.03$4.88686,791 shs$286.34 million05/28/2024$5.23$4.98-4.78%$5.22$4.861.07 million shs$289.84 million05/27/2024$5.23$5.23$5.23$4.91896,800 shs$304.38 million05/24/2024$4.91$5.23+6.52%$5.23$4.91877,649 shs$304.39 million Get the Latest News and Ratings for VNDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$5.14$4.91-4.47%$5.13$4.88847,524 shs$285.76 million05/22/2024$5.11$5.14+0.59%$5.19$5.05700,640 shs$299.15 million05/21/2024$5.27$5.11-3.04%$5.29$5.08769,723 shs$297.40 million05/20/2024$5.48$5.27-3.83%$5.48$5.26685,390 shs$306.71 million05/17/2024$5.58$5.48-1.79%$5.69$5.47788,058 shs$318.94 million05/16/2024$5.36$5.58+4.10%$5.62$5.331.08 million shs$324.76 million05/15/2024$5.13$5.36+4.48%$5.39$5.16907,855 shs$311.95 million05/14/2024$5.05$5.13+1.58%$5.16$5.04774,271 shs$298.57 million05/13/2024$5.04$5.05+0.20%$5.14$4.96832,736 shs$293.91 million05/10/2024$5.01$5.04+0.60%$5.08$4.871.38 million shs$293.32 million05/09/2024$5.36$5.01-6.53%$5.38$4.941.97 million shs$291.57 million05/08/2024$5.48$5.36-2.19%$5.64$5.311.97 million shs$311.94 million05/07/2024$4.84$5.48+13.22%$5.95$5.174.71 million shs$318.94 million05/06/2024$4.88$4.84-0.82%$5.03$4.791.28 million shs$281.69 million05/03/2024$4.68$4.88+4.27%$4.91$4.70651,259 shs$284.02 million05/02/2024$4.77$4.68-1.89%$4.84$4.67845,884 shs$272.38 million05/01/2024$4.76$4.77+0.21%$4.90$4.621.75 million shs$274.47 million04/30/2024$4.82$4.76-1.24%$4.82$4.71539,640 shs$273.89 million04/29/2024$4.62$4.82+4.33%$4.85$4.66821,763 shs$277.34 million04/26/2024$4.48$4.62+3.12%$4.63$4.45821,939 shs$265.84 million04/25/2024$4.56$4.48-1.75%$4.57$4.43922,253 shs$257.78 million04/24/2024$4.63$4.56-1.51%$4.67$4.551.18 million shs$262.38 million04/23/2024$4.80$4.63-3.54%$4.87$4.621.37 million shs$266.41 million04/22/2024$5.11$4.80-6.07%$5.12$4.792.11 million shs$276.19 million04/19/2024$4.97$5.11+2.82%$5.30$4.932.44 million shs$294.03 million04/18/2024$5.24$4.97-5.15%$5.25$4.903.86 million shs$285.97 million04/17/2024$4.05$5.24+29.38%$5.67$4.9923.86 million shs$301.51 million04/16/2024$4.06$4.05-0.25%$4.08$3.99789,213 shs$233.04 million04/15/2024$4.12$4.06-1.46%$4.16$4.01784,517 shs$233.61 million04/12/2024$4.28$4.12-3.74%$4.30$4.08762,047 shs$237.07 million04/11/2024$4.28$4.28$4.32$4.18766,820 shs$246.27 million04/10/2024$4.36$4.28-1.83%$4.37$4.141.16 million shs$246.27 million04/09/2024$4.51$4.36-3.33%$4.68$4.341.79 million shs$250.86 million04/08/2024$4.82$4.51-6.43%$4.83$4.491.69 million shs$259.51 millionLEAKED: Jeff Bezos' $330 Million Gamble (Ad)Did you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough.Here's how you could invest alongside them >>>04/05/2024$4.92$4.82-2.03%$4.99$4.791.67 million shs$277.34 million04/04/2024$5.05$4.92-2.57%$5.44$4.846.15 million shs$283.10 million04/03/2024$3.91$5.05+29.16%$6.03$4.3750.66 million shs$290.58 million04/02/2024$4.12$3.91-5.10%$4.02$3.87915,525 shs$224.98 million04/01/2024$4.11$4.12+0.24%$4.24$4.09729,037 shs$237.07 million03/29/2024$4.11$4.11$4.19$3.911.37 million shs$236.48 million03/28/2024$3.89$4.11+5.66%$4.19$3.911.37 million shs$236.49 million03/27/2024$3.86$3.89+0.78%$3.92$3.86799,311 shs$223.83 million03/26/2024$3.87$3.86-0.26%$3.98$3.86604,356 shs$222.10 million03/25/2024$3.89$3.87-0.51%$3.98$3.86593,577 shs$222.68 million03/22/2024$3.91$3.89-0.51%$3.98$3.85513,805 shs$223.83 million03/21/2024$3.80$3.91+2.89%$3.97$3.79883,248 shs$224.98 million03/20/2024$3.76$3.80+1.06%$3.85$3.71613,527 shs$218.65 million03/19/2024$3.75$3.76+0.27%$3.83$3.72606,368 shs$216.35 million03/18/2024$3.81$3.75-1.57%$3.84$3.72664,615 shs$215.78 million03/15/2024$3.80$3.81+0.26%$3.88$3.771.12 million shs$219.23 million03/14/2024$3.84$3.80-1.04%$3.88$3.79714,470 shs$218.65 million03/13/2024$3.88$3.84-1.03%$3.97$3.82756,806 shs$220.95 million03/12/2024$4.01$3.88-3.12%$4.01$3.88604,594 shs$223.26 million03/11/2024$3.87$4.01+3.49%$4.07$3.92798,481 shs$230.45 million03/08/2024$3.82$3.87+1.31%$3.97$3.851.16 million shs$222.68 million03/07/2024$3.91$3.82-2.30%$3.97$3.81963,020 shs$219.80 million03/06/2024$4.14$3.91-5.56%$4.09$3.911.54 million shs$224.98 million03/05/2024$4.27$4.14-3.04%$4.35$4.12853,957 shs$245.68 million03/04/2024$4.61$4.27-7.38%$4.67$4.221.53 million shs$245.70 million03/01/2024$4.47$4.61+3.13%$4.72$4.471.13 million shs$265.25 million Related Companies: Gossamer Bio Stock Chart VBI Vaccines Stock Chart AnaptysBio Stock Chart Innoviva Stock Chart OPKO Health Stock Chart Ironwood Pharmaceuticals Stock Chart Lexicon Pharmaceuticals Stock Chart Agenus Stock Chart XOMA Stock Chart Emergent BioSolutions Stock Chart Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VNDA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.